Steris (STE) Cash & Current Investments (2017 - 2026)
Steris' (STE) quarterly Cash & Current Investments came in at $439.6 million in Q1 2026, up 156.03% year-on-year from $171.7 million in Q1 2025, and up 3.75% quarter-over-quarter from $423.7 million in Q4 2025.
Steris (STE) Cash & Current Investments (2017 - 2026) Analysis & Trends
Steris' Cash & Current Investments history runs 10 years deep, the most recent figure standing at $439.6 million for Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 156.03% year-over-year to $439.6 million in Q1 2026; TTM through Mar 2026 was $439.6 million, a 156.03% increase from a year earlier, with the FY2026 full-year figure at $439.6 million, up 156.03% from the prior year.
- Cash & Current Investments grew to $439.6 million in Q1 2026 per STE's latest filing, from $423.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $439.6 million in Q1 2026 and bottomed at $155.2 million in Q4 2024.
- The 5-year median for Cash & Current Investments is $213.8 million (2023), against an average of $257.4 million.
- Across the five-year window, Cash & Current Investments plunged 40.85% in 2022 and jumped 173.04% in 2025, its largest moves.
- Year by year, Cash & Current Investments stood at $259.4 million in 2022, then dropped by 24.59% to $195.6 million in 2023, then dropped by 20.66% to $155.2 million in 2024, then surged by 173.04% to $423.7 million in 2025, then climbed by 3.75% to $439.6 million in 2026.
- Per Business Quant, the three latest STE Cash & Current Investments figures stand at $439.6 million (Q1 2026), $423.7 million (Q4 2025), and $319.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.12 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 577.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 439.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 439.60 Mn |
| Dec 31, 2025 | 423.70 Mn |
| Sep 30, 2025 | 319.20 Mn |
| Jun 30, 2025 | 279.70 Mn |
| Mar 31, 2025 | 171.70 Mn |
| Dec 31, 2024 | 155.18 Mn |
| Sep 30, 2024 | 172.20 Mn |
| Jun 30, 2024 | 198.33 Mn |
| Mar 31, 2024 | 207.00 Mn |
| Dec 31, 2023 | 195.59 Mn |
| Sep 30, 2023 | 213.76 Mn |
| Jun 30, 2023 | 208.61 Mn |
| Mar 31, 2023 | 208.40 Mn |
| Dec 31, 2022 | 259.37 Mn |
| Sep 30, 2022 | 258.26 Mn |
| Jun 30, 2022 | 316.33 Mn |
| Mar 31, 2022 | 348.32 Mn |
| Dec 31, 2021 | 359.09 Mn |
| Sep 30, 2021 | 383.49 Mn |
| Jun 30, 2021 | 534.77 Mn |